NCT02991456 2023-07-11Rolapitant as an Antiemetic in Malignant Glioma Patients Receiving Radiotherapy and TemozolomideDuke UniversityPhase 2 Completed48 enrolled 25 charts
NCT01450826 2018-06-26Emend and Ondansetron Compared to Ondansetron Alone to Prevent CINV in Glioma Patients Receiving TemozolomideDuke UniversityPhase 2 Completed136 enrolled 10 charts
NCT00795769 2017-05-23Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell TransplantFred Hutchinson Cancer CenterPhase 2 Completed49 enrolled 4 charts
NCT00248547 2017-05-09Aprepitant in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell TransplantOHSU Knight Cancer InstitutePhase NA Completed40 enrolled 8 charts